Back to All Events

"50 Years of Ebolaviruses: From Zaire ebolavirus to the Bundibugyo virus Emergency" with Nadine Biedenkopf – PandA webinar series

When: 13 August, 2026, 15:00–16:30

Where: Online via Zoom (link provided upon registration)

Speaker: Nadine Biedenkopf, the Institute of Virology, Philipps-University Marburg

Title: 50 Years of Ebolaviruses: From Zaire ebolavirus to the Bundibugyo virus Emergency

Abstract

Fifty years after the simultaneous discovery of Ebola virus and Sudan virus in 1976, filoviruses continue to pose a critical threat to global health security, a reality underscored by the ongoing Bundibugyo virusoutbreak in the DRC and Uganda since May 2026. Deciphering core replication mechanisms is essential for identifying highly conserved vulnerabilities across the Filovirus family. This seminar highlights experimental approaches to investigate these high-consequence pathogens. Particular focus is placed on the application of life-cycle modeling assays to dissect individual steps of the viral life cycle, enabling detailed insights into critical virus-host interactions and driving the development of broad-spectrum, pan-filoviral strategies. 

Biography

Nadine Biedenkopf studied human biology at the Philipps-University Marburg, Germany, specializing early on in infection biology. During her doctoral and postdoctoral research at the Institute of Virology in Marburg, she focused intensively on the viral transcription and replication of the highly pathogenic Ebola virus. Since 2019, she has been group leader at the institute. Her research deciphers the molecular mechanisms driving highly pathogenic RNA virus replication by utilizing life cycle modeling assays and advanced reverse genetics. Taking an interdisciplinary approach, her lab explores dynamic virus-host interactions, focusing specifically on how post-translational modifications and viral RNA structures regulate transcription and replication in filoviruses and coronaviruses. Her work bridges fundamental molecular virology with translational science to identify novel antiviral targets and broad-spectrum therapeutic strategies. Additionally, she is actively involved in preclinical vaccine development against highly pathogenic viruses.


If you don’t receive a registration confirmation please check your spam mail.

During our events we sometimes take photographs and short film clips to profile our activities. Please let us know if you don’t want to be in any photos/films before we start the event. Some webinars are recorded to be used for educational purposes in the LINXS website.

By registering to our events you give your permission to LINXS, according to the General Data Protection Regulation (GDPR), to register your name and e-mail address to be used for the sole purpose of distributing newsletters and communications on LINXS activities.